Related Experiment Video

Updated: Jan 22, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

15.9K

Patient-reported study of the impact of pediatric-onset myotonic dystrophy

Michael Hunter1, Anne-Berit Ekstrom2, Craig Campbell3

  • 1Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah.

Muscle & Nerve
|July 13, 2019
PubMed

Insights

Pediatric myotonic dystrophy type-1 (DM1) significantly impacts daily life, with hand and gastrointestinal issues being most common. Understanding these symptoms is crucial for improving patient care and quality of life.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • The prevalence and impact of symptoms in pediatric myotonic dystrophy type-1 (DM1) are not well understood.
  • Pediatric-onset DM1 affects multiple body systems, leading to a range of debilitating symptoms.
  • Comprehensive understanding of symptom burden is essential for effective management.

Purpose of the Study:

  • To investigate the prevalence and impact of 20 themes associated with pediatric-onset DM1.
  • To compare patient and caregiver perspectives on symptom burden.
  • To identify key areas for intervention and support in pediatric DM1.

Main Methods:

  • A survey was administered to patients and caregivers in the United States, Canada, and Sweden.
  • Participants reported the prevalence and importance of 20 themes related to pediatric DM1.
  • Patient and caregiver survey responses were matched for comparative analysis.

Main Results:

  • The most prevalent symptoms included hand/finger problems (79%) and gastrointestinal issues (75%).
  • Urinary/bowel control and gastrointestinal problems had the greatest impact on patients' lives.
  • Agreement between patient and caregiver responses varied across symptomatic themes.

Conclusions:

  • Multiple symptoms significantly contribute to the overall disease burden in pediatric DM1.
  • Physical activity themes showed the highest agreement between patients and caregivers.
  • Further research is needed to address the diverse symptomatic impacts of pediatric DM1.
Abstract

Keywords:
caregivershealth status indicatorsmyotonic dystrophyneuromuscular diseasepediatric onsetsymptom assessment

More Related Videos

Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.2K
A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy05:54

A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy

Published on: December 29, 2017

10.5K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
269
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
198
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Data Reporting and Recording01:24

Data Reporting and Recording

Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.4K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K